Chris Wink is the co-founder of the legendary Blue Man Group, and has recently opened an immersive psychedelic funhouse exhibit in Las Vegas called Wink...
Peyton Nyquvest is the CEO of Numinus, a Canadian publicly-traded company that is involved in psychedelic synthesis, research and treatment. Numinous recently...
What makes a work of art truly transcendent? Is it an exhibition of mastery, or an abundance of mystery? Is it the presence of genius, or...
This is the first article in a series investigating the Church of Psilomethoxin (CoP), exploring the recent debate about the Church's sacrament and the...
Cybin Inc. (NEO:CYBN / NYSE American:CYBN) a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new...
The firm has made meaningful strides in its early clinical runway as it gears up for government-funded studies. The post Awakn Life Sciences’ Revenue...
The article LSD for Depression: A Closer Look was originally published on Microdose. As the search for effective treatments for depression continues,...
Executive Director William Garner now owns or exercises control over nearly 40% of common shares. The post Tryp Therapeutics Raises AUD$2.4 Million appeared...
Peter MD's acquisition of the ketamine clinics faced many hurdles. The post The Inside Story Behind Ketamine Wellness Centers’ Fallout appeared first...
Breaking Convention in Exeter is the indie label equivalent to the corporadelic mega conventions taking over across the psychedelic realm, with equal emphasis...